Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Change in Cash (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Change in Cash for 16 consecutive years, with $1.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Cash fell 72.76% to $1.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.6 million, a 12.48% increase, with the full-year FY2024 number at -$945648.0, up 95.53% from a year prior.
  • Change in Cash was $1.9 million for Q3 2025 at GeoVax Labs, up from -$4.3 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $14.6 million in Q2 2022 to a low of -$7.1 million in Q4 2022.
  • A 5-year average of -$256568.4 and a median of -$1.4 million in 2021 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: soared 17909.64% in 2021, then tumbled 648.01% in 2025.
  • GeoVax Labs' Change in Cash stood at -$6.7 million in 2021, then fell by 5.7% to -$7.1 million in 2022, then grew by 11.75% to -$6.2 million in 2023, then skyrocketed by 50.51% to -$3.1 million in 2024, then skyrocketed by 162.07% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Change in Cash are $1.9 million (Q3 2025), -$4.3 million (Q2 2025), and $1.9 million (Q1 2025).